Back to Journals » Vascular Health and Risk Management » Volume 3 » Issue 5
Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,479 | Dovepress* | 6,479+ | 2,599 | 9,078 | |
Totals | 6,479 | 2,599 | 9,078 | ||
*Since 15 November 2007 +Since July 2016 |
View citations on Google Scholar